Pulse lineResearch With Heart Logo

ARIC Publications

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Lindström S, Germain M, Crous-Bou M, et al. "Assessing the causal relationship between obesity and venous thromboembolism through a Mendelian Randomization study." Hum Genet. 2017;136(7):897-902.
Guo Y, Musani SK, Sims M, Pearson TA, DeBoer MD. "Assessing the added predictive ability of a metabolic syndrome severity score in predicting incident cardiovascular disease and type 2 diabetes: the Atherosclerosis Risk in Communities Study and Jackson Heart Study." Diabetol Metab Syndr. 2018;10:42.
Zhou L, Stearns SC, Thudium EM, Alburikan KA. "Assessing Medicare Part D claim completeness using medication self-reports: the role of veteran status and Generic Drug Discount Programs." Med Care. 2015;53(5):463-70.
Nichols E, Deal JA, Swenor BK, et al. "Assessing Bias in Cognitive Testing for Older Adults with Sensory Impairment: An Analysis of Differential Item Functioning in the Baltimore Longitudinal Study on Aging (BLSA) and the Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS)." J Int Neuropsychol Soc. 2021:1-12.
Hurwitz LM, Joshu CE, Barber JR, et al. "Aspirin and Non-Aspirin NSAID Use and Prostate Cancer Incidence, Mortality, and Case Fatality in the Atherosclerosis Risk in Communities Study." Cancer Epidemiol Biomarkers Prev. 2019;28(3):563-569.
Moore CR, Jain S, Haas S, et al. "Ascertaining Framingham heart failure phenotype from inpatient electronic health record data using natural language processing: a multicentre Atherosclerosis Risk in Communities (ARIC) validation study." BMJ Open. 2021;11(6):e047356.
Burke GL, Evans GW, Riley WA, et al. "Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study." Stroke. 1995;26(3):386-91.
Din-Dzietham R, Couper D, Evans G, Arnett DK, Jones DW. "Arterial stiffness is greater in African Americans than in whites: evidence from the Forsyth County, North Carolina, ARIC cohort." Am J Hypertens. 2004;17(4):304-13.
Liao D, Arnett DK, Tyroler HA, et al. "Arterial stiffness and the development of hypertension. The ARIC study." Hypertension. 1999;34(2):201-6.
Hughes TM, Wagenknecht LE, Craft S, et al. "Arterial stiffness and dementia pathology: Atherosclerosis Risk in Communities (ARIC)-PET Study." Neurology. 2018;90(14):e1248-e1256.
Crouse JR, Goldbourt U, Evans G, et al. "Arterial enlargement in the atherosclerosis risk in communities (ARIC) cohort. In vivo quantification of carotid arterial enlargement. The ARIC Investigators." Stroke. 1994;25(7):1354-9.
Schmitz KH, Arnett DK, Bank A, et al. "Arterial distensibility and physical activity in the ARIC study." Med Sci Sports Exerc. 2001;33(12):2065-71.
Gottesman RF, Schneider ALC, Zhou Y, et al. "The ARIC-PET amyloid imaging study: Brain amyloid differences by age, race, sex, and APOE." Neurology. 2016;87(5):473-80.
Nguyen ND, Ghaddar H, Stinson V, Chambless LE, Wu KK. "ARIC hemostasis study--IV. Intraindividual variability and reliability of hemostatic factors. The Atherosclerosis Risk in Communities (ARIC)." Thromb Haemost. 1995;73(2):256-60.
Chambless LE, McMahon R, Finch A, et al. "ARIC hemostasis study--III. Quality control. Atherosclerosis Risk in Communities." Thromb Haemost. 1993;70(4):588-94.
Wu KK, Papp AC, Patsch W, Rock R, Eckfeldt J, Sharrett R. "ARIC hemostasis study--II. Organizational plan and feasibility study." Thromb Haemost. 1990;64(4):521-5.
Papp AC, Hatzakis H, Bracey A, Wu KK. "ARIC hemostasis study--I. Development of a blood collection and processing system suitable for multicenter hemostatic studies." Thromb Haemost. 1989;61(1):15-9.
Matijevic N, Wu KK, Nidkarni N, Heiss G, Folsom AR. "The ARIC carotid MRI study of blood cellular markers: an inverse association of monocyte myeloperoxidase content with peripheral arterial disease." Angiology. 2011;62(3):237-44.
Wright JD, Folsom AR, Coresh J, et al. "The ARIC (Atherosclerosis Risk In Communities) Study: JACC Focus Seminar 3/8." J Am Coll Cardiol. 2021;77(23):2939-2959.
Merkin S S, Coresh J, Diez Roux AV, Taylor HA, Powe NR. "Area socioeconomic status and progressive CKD: the Atherosclerosis Risk in Communities (ARIC) Study." Am J Kidney Dis. 2005;46(2):203-13.
Diez-Roux AV, Kiefe CI, Jacobs DR, et al. "Area characteristics and individual-level socioeconomic position indicators in three population-based epidemiologic studies." Ann Epidemiol. 2001;11(6):395-405.
Kaufman BG, Sueta CA, Chen C, B Windham G. "Are Trends in Hospitalization Prior to Hospice Use Associated With Hospice Episode Characteristics?" Am J Hosp Palliat Care. 2017;34(9):860-868.
"Are There Clinical Implications of Racial Differences in HbA1c? A Difference, to Be a Difference, Must Make a Difference." Diabetes Care. 2016;39(8):1462-7.
Klein R, Sharrett AR, Klein BE, et al. "Are retinal arteriolar abnormalities related to atherosclerosis?: The Atherosclerosis Risk in Communities Study." Arterioscler Thromb Vasc Biol. 2000;20(6):1644-50.
Weitzman S, Wang C-H, Pankow JS, Schmidt MI, Brancati FL. "Are measures of height and leg length related to incident diabetes mellitus? The ARIC (Atherosclerosis Risk in Communities) study." Acta Diabetol. 2010;47(3):237-42.
Moorthy S, Cheung N, Klein R, Shahar E, Wong TY. "Are lung disease and function related to age-related macular degeneration?" Am J Ophthalmol. 2011;151(2):375-9.
Gross AL, Power MC, Albert MS, et al. "Application of Latent Variable Methods to the Study of Cognitive Decline When Tests Change over Time." Epidemiology. 2015;26(6):878-87.
Selvaraj S, Myhre PL, Vaduganathan M, et al. "Application of Diagnostic Algorithms for Heart Failure With Preserved Ejection Fraction to the Community." JACC Heart Fail. 2020;8(8):640-653.
Ndumele CE, Matsushita K, Astor B, et al. "Apolipoproteins do not add prognostic information beyond lipoprotein cholesterol measures among individuals with obesity and insulin resistance syndromes: the ARIC study." Eur J Prev Cardiol. 2014;21(7):866-75.
Shachter NS. "Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism." Curr Opin Lipidol. 2001;12(3):297-304.
Volcik KA, Barkley R A, Hutchinson RG, et al. "Apolipoprotein E polymorphisms predict low density lipoprotein cholesterol levels and carotid artery wall thickness but not incident coronary heart disease in 12,491 ARIC study participants." Am J Epidemiol. 2006;164(4):342-8.
Boerwinkle E, Brown S, Sharrett AR, Heiss G, Patsch W. "Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations." Am J Hum Genet. 1994;54(2):341-60.
Selvaraj S, Claggett B, Johansen MC, et al. "Apolipoprotein E Polymorphism, Cardiac Remodeling, and Heart Failure in the ARIC Study." J Card Fail. 2022;28(7):1128-1136.
Surguchov AP, Boerwinkle E, Sharett AR, Patsch WP. "Apolipoprotein E genotype and lipid transport: insight into the role of the epsilon 4 allele." Atherosclerosis. 1994;106(1):119-21.
Sturgeon JD, Folsom AR, Bray MS, Boerwinkle E, Ballantyne CM. "Apolipoprotein E genotype and incident ischemic stroke: the Atherosclerosis Risk in Communities Study." Stroke. 2005;36(11):2484-6.
Boland LL, Folsom AR, Boerwinkle E. "Apolipoprotein E genotype and gallbladder disease risk in a large population-based cohort." Ann Epidemiol. 2006;16(10):763-9.
Liew G, Shankar A, Wang J J, et al. "Apolipoprotein E gene polymorphisms and retinal vascular signs: the atherosclerosis risk in communities (ARIC) study." Arch Ophthalmol. 2007;125(6):813-8.
Wong T Y, Shankar A, Klein R, et al. "Apolipoprotein E gene and early age-related maculopathy: the Atherosclerosis Risk in Communities Study." Ophthalmology. 2006;113(2):255-9.
Hsu CC, Kao LWH, Coresh J, et al. "Apolipoprotein E and progression of chronic kidney disease." JAMA. 2005;293(23):2892-9.
Foster MC, Coresh JJ, Fornage M, et al. "APOL1 variants associate with increased risk of CKD among African Americans." J Am Soc Nephrol. 2013;24(9):1484-91.
Klos K, Shimmin L, Ballantyne C, et al. "APOE/C1/C4/C2 hepatic control region polymorphism influences plasma apoE and LDL cholesterol levels." Hum Mol Genet. 2008;17(13):2039-46.
Maxwell TJ, Ballantyne CM, Cheverud JM, Guild CS, Ndumele CE. "APOE modulates the correlation between triglycerides, cholesterol, and CHD through pleiotropy, and gene-by-gene interactions." Genetics. 2013;195(4):1397-405.
Blair CK, Folsom AR, Knopman DS, Bray MS, Mosley TH, Boerwinkle E. "APOE genotype and cognitive decline in a middle-aged cohort." Neurology. 2005;64(2):268-76.
Pokharel Y, Mouhanna F, Nambi V, et al. "ApoB, small-dense LDL-C, Lp(a), LpPLA activity, and cognitive change." Neurology. 2019;92(22):e2580-e2593.
Stone K, Fryer S, Faulkner J, et al. "The aortic-femoral arterial stiffness gradient is blood pressure independent in older adults: the atherosclerosis risk in communities (ARIC) study." J Hypertens. 2021.
Stone K, Fryer S, Meyer ML, et al. "The aortic-femoral arterial stiffness gradient: an atherosclerosis risk in communities (ARIC) study." J Hypertens. 2021.
Wei J, Palta P, Meyer ML, et al. "Aortic Stiffness and White Matter Microstructural Integrity Assessed by Diffusion Tensor Imaging: The ARIC-NCS." J Am Heart Assoc. 2020;9(6):e014868.
Conlan MG, Folsom AR, Finch A, et al. "Antithrombin III: associations with age, race, sex and cardiovascular disease risk factors. The Atherosclerosis Risk in Communities (ARIC) Study Investigators." Thromb Haemost. 1994;72(4):551-6.
Ding J, Davis-Plourde KL, Sedaghat S, et al. "Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies." Lancet Neurol. 2020;19(1):61-70.
Federspiel JJ, Sueta CA, Kucharska-Newton AMaria, et al. "Antihypertensive adherence and outcomes among community-dwelling Medicare beneficiaries: the Atherosclerosis Risk in Communities Study." J Eval Clin Pract. 2018;24(1):48-55.
Iso H, Folsom AR, Koike KA, et al. "Antigens of tissue plasminogen activator and plasminogen activator inhibitor 1: correlates in nonsmoking Japanese and Caucasian men and women." Thromb Haemost. 1993;70(3):475-80.
Runchey SS, Folsom AR, Tsai MY, Cushman M, McGovern PD. "Anticardiolipin antibodies as a risk factor for venous thromboembolism in a population-based prospective study." Br J Haematol. 2002;119(4):1005-10.
Kshirsagar AV, Offenbacher S, Moss KL, Barros SP, Beck JD. "Antibodies to periodontal organisms are associated with decreased kidney function. The Dental Atherosclerosis Risk In Communities study." Blood Purif. 2007;25(1):125-32.
Wang FM, Yang C, Ballew SH, et al. "Ankle-brachial index and subsequent risk of incident and recurrent cardiovascular events in older adults: The Atherosclerosis Risk in Communities (ARIC) study." Atherosclerosis. 2021;336:39-47.
Matsushita K, Ballew SH, Sang Y, et al. "Ankle-brachial index and physical function in older individuals: The Atherosclerosis Risk in Communities (ARIC) study." Atherosclerosis. 2017;257:208-215.
Hua S, Loehr LR, Tanaka H, Heiss G, Coresh JJ, Selvin E. "Ankle-brachial index and incident diabetes mellitus: the atherosclerosis risk in communities (ARIC) study." Cardiovasc Diabetol. 2016;15(1):163.
Reich LM, Heiss G, Boland LL, Hirsch AT, Wu K, Folsom AR. "Ankle-brachial index and hemostatic markers in the Atherosclerosis Risk in Communities (ARIC) study cohort." Vasc Med. 2007;12(4):267-73.
Tsai AW, Folsom AR, Rosamond WD, Jones DW. "Ankle-brachial index and 7-year ischemic stroke incidence: the ARIC study." Stroke. 2001;32(8):1721-4.
Kshirsagar AV, Coresh J, Brancati F, Colindres RE. "Ankle brachial index independently predicts early kidney disease." Ren Fail. 2004;26(4):433-43.
Stitziel NO, Khera AV, Wang X, et al. "ANGPTL3 Deficiency and Protection Against Coronary Artery Disease." J Am Coll Cardiol. 2017;69(16):2054-2063.
Arnett DK, Borecki IB, Ludwig EH, et al. "Angiotensinogen and angiotensin converting enzyme genotypes and carotid atherosclerosis: the atherosclerosis risk in communities and the NHLBI family heart studies." Atherosclerosis. 1998;138(1):111-6.
Golden S H, Williams JE, Ford DE, et al. "Anger temperament is modestly associated with the risk of type 2 diabetes mellitus: the Atheroslcerosis Risk in Communities Study." Psychoneuroendocrinology. 2006;31(3):325-32.
Williams JE, Paton CC, Siegler IC, Eigenbrodt ML, Nieto FJ, Tyroler HA. "Anger proneness predicts coronary heart disease risk: prospective analysis from the atherosclerosis risk in communities (ARIC) study." Circulation. 2000;101(17):2034-9.
Kucharska-Newton AMaria, Williams JE, Chang PP, Stearns SC, Sueta CA, Blecker SB. "Anger proneness, gender, and the risk of heart failure." J Card Fail. 2014;20(12):1020-6.
McAdams-Demarco MA, Maynard JW, Coresh J, Baer AN. "Anemia and the onset of gout in a population-based cohort of adults: Atherosclerosis Risk in Communities study." Arthritis Res Ther. 2012;14(4):R193.
Yeap BBeng, Marriott RJames, Adams RJ, et al. "Androgens In Men Study (AIMS): protocol for meta-analyses of individual participant data investigating associations of androgens with health outcomes in men." BMJ Open. 2020;10(5):e034777.
Li M, Li Y, Weeks O, et al. " and Loci Identified through Large-Scale Exome Chip Analysis Regulate Kidney Development and Function." J Am Soc Nephrol. 2017;28(3):981-994.
Böger CA, Gorski M, McMahon GM, et al. " and Loci Associate with Plasma Osmolality." J Am Soc Nephrol. 2017;28(8):2311-2321.
Ma Y, Jun GR, Zhang X, et al. "Analysis of Whole-Exome Sequencing Data for Alzheimer Disease Stratified by APOE Genotype." JAMA Neurol. 2019.
Direk N, Williams S, Smith JA, et al. "An Analysis of Two Genome-wide Association Meta-analyses Identifies a New Locus for Broad Depression Phenotype." Biol Psychiatry. 2017;82(5):322-329.
Tao R, Zeng D, Franceschini N, North KE, Boerwinkle E. "Analysis of Sequence Data Under Multivariate Trait-Dependent Sampling." J Am Stat Assoc. 2015;110(510):560-572.
Nandakumar P, Lee D, Hoffmann TJ, et al. "Analysis of putative cis-regulatory elements regulating blood pressure variation." Hum Mol Genet. 2020;29(11):1922-1932.
Carty CL, Bhattacharjee S, Haessler J, et al. "Analysis of metabolic syndrome components in >15 000 african americans identifies pleiotropic variants: results from the population architecture using genomics and epidemiology study." Circ Cardiovasc Genet. 2014;7(4):505-13.
Li AH, Morrison AC, Kovar C, et al. "Analysis of loss-of-function variants and 20 risk factor phenotypes in 8,554 individuals identifies loci influencing chronic disease." Nat Genet. 2015;47(6):640-2.
Chambless LE, Davis V. "Analysis of associations with change in a multivariate outcome variable when baseline is subject to measurement error." Stat Med. 2003;22(7):1041-67.
Fu W, O'Connor TD, Jun G, et al. "Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants." Nature. 2013;493(7431):216-20.
Brody JA, Morrison AC, Bis JC, et al. "Analysis commons, a team approach to discovery in a big-data environment for genetic epidemiology." Nat Genet. 2017;49(11):1560-1563.
Charles BA, Hsieh MM, Adeyemo AA, et al. "Analyses of genome wide association data, cytokines, and gene expression in African-Americans with benign ethnic neutropenia." PLoS One. 2018;13(3):e0194400.
C Quarta C, Buxbaum JN, Shah AM, et al. "The amyloidogenic V122I transthyretin variant in elderly black Americans." N Engl J Med. 2015;372(1):21-9.
Folsom AR, Shah AM, Lutsey PL, et al. "American Heart Association's Life's Simple 7: Avoiding Heart Failure and Preserving Cardiac Structure and Function." Am J Med. 2015;128(9):970-6.e2.